Equities

European Medical Solutions SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

European Medical Solutions SA

Actions
  • Price (EUR)4.78
  • Today's Change4.78 / --
  • Shares traded--
  • 1 Year change--
  • Beta0.8140
Data delayed at least 20 minutes, as of Jan 29 2026 08:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

European Medical Solutions SA is a Belgium-based company that mainly focuses on medical imaging technology solutions. The Company offers a complete range of medical imaging systems on the international market. It is engaged in the design and manufacturing of imaging systems for digital and conventional radiology and bone densitometry. It offers products such as: X-ray equipment (mobile X-ray units, floating panel tables, movable poles for operating theatres, etc.), ultrasonic bone densitometers (for the reconstruction of bone microarchitecture), X-ray bone densitometers (for bone density measurement), etc.

  • Revenue in EUR (TTM)46.78m
  • Net income in EUR1.17m
  • Incorporated1997
  • Employees123.00
  • Location
    European Medical Solutions SAAvenue Louise 231BRUXELLES 1050BelgiumBEL
  • Phone+32 467504900
  • Fax+32 467504909
  • Websitehttps://www.dms-imaging.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.